Nelson BH - Search Results

1

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival.

Brown SD, Warren RL, Gibb EA, Martin SD, Spinelli JJ, Nelson BH, Holt RA. Brown SD, et al. Among authors: nelson bh. Genome Res. 2014 May;24(5):743-50. doi: 10.1101/gr.165985.113. Epub 2014 Apr 29. Genome Res. 2014. PMID: 24782321 Free PMC article.

2

Profiling model T-cell metagenomes with short reads.

Warren RL, Nelson BH, Holt RA. Warren RL, et al. Among authors: nelson bh. Bioinformatics. 2009 Feb 15;25(4):458-64. doi: 10.1093/bioinformatics/btp010. Epub 2009 Jan 9. Bioinformatics. 2009. PMID: 19136549

3

Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing.

Freeman JD, Warren RL, Webb JR, Nelson BH, Holt RA. Freeman JD, et al. Among authors: nelson bh. Genome Res. 2009 Oct;19(10):1817-24. doi: 10.1101/gr.092924.109. Epub 2009 Jun 18. Genome Res. 2009. PMID: 19541912 Free PMC article.

4

Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C).

Wick DA, Martin SD, Nelson BH, Webb JR. Wick DA, et al. Among authors: nelson bh. Vaccine. 2011 Jan 29;29(5):984-93. doi: 10.1016/j.vaccine.2010.11.036. Epub 2010 Nov 27. Vaccine. 2011. PMID: 21115055

5

Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease.

Castellarin M, Milne K, Zeng T, Tse K, Mayo M, Zhao Y, Webb JR, Watson PH, Nelson BH, Holt RA. Castellarin M, et al. Among authors: nelson bh. J Pathol. 2013 Mar;229(4):515-24. doi: 10.1002/path.4105. Epub 2012 Nov 29. J Pathol. 2013. PMID: 22996961

6

Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.

West NR, Kost SE, Martin SD, Milne K, Deleeuw RJ, Nelson BH, Watson PH. West NR, et al. Among authors: nelson bh. Br J Cancer. 2013 Jan 15;108(1):155-62. doi: 10.1038/bjc.2012.524. Epub 2012 Nov 20. Br J Cancer. 2013. PMID: 23169287 Free PMC article.

7

Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.

Wick DA, Webb JR, Nielsen JS, Martin SD, Kroeger DR, Milne K, Castellarin M, Twumasi-Boateng K, Watson PH, Holt RA, Nelson BH. Wick DA, et al. Among authors: nelson bh. Clin Cancer Res. 2014 Mar 1;20(5):1125-34. doi: 10.1158/1078-0432.CCR-13-2147. Epub 2013 Dec 9. Clin Cancer Res. 2014. PMID: 24323902

8

PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer.

Webb JR, Milne K, Nelson BH. Webb JR, et al. Among authors: nelson bh. Cancer Immunol Res. 2015 Aug;3(8):926-35. doi: 10.1158/2326-6066.CIR-14-0239. Epub 2015 May 8. Cancer Immunol Res. 2015. PMID: 25957117

9

Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era.

Martin SD, Coukos G, Holt RA, Nelson BH. Martin SD, et al. Among authors: nelson bh. Ann Oncol. 2015 Dec;26(12):2367-74. doi: 10.1093/annonc/mdv382. Epub 2015 Sep 14. Ann Oncol. 2015. PMID: 26371284 Free PMC article. Review.

10

Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.

Martin SD, Brown SD, Wick DA, Nielsen JS, Kroeger DR, Twumasi-Boateng K, Holt RA, Nelson BH. Martin SD, et al. Among authors: nelson bh. PLoS One. 2016 May 18;11(5):e0155189. doi: 10.1371/journal.pone.0155189. eCollection 2016. PLoS One. 2016. PMID: 27192170 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters